OnKure sets Diamond in C-suite ahead of Pfizer drug combo trial

OnKure Therapeutics has put another piece of its C-suite in place, hiring Jennifer Diamond, M.D., as chief medical officer to support clinical development of its pipeline of cancer medicines.

Since raising a $55 million series B round in March, OnKure has built out its leadership team with a series of key hires. James Winkler, Ph.D., and Duncan Walker, Ph.D., came on board as chief scientific officer and chief development officer, respectively, over the summer to address two gaps in the team. Now, OnKure has secured expertise in early-phase clinical trials through the appointment of Diamond.